REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biomin, A.S. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biomin, A.S. Profile Updated: October 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Biomin, A.S. is a company based in Slovakia, with its head office in Cifer. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on July 25, 1990. The total number of employees is currently 25 - 49 (2023). The company’s latest financial report indicates a net sales revenue increase of 19.09% in 2023. Its’ total assets recorded a negative growth of 7.67%. The net profit margin of Biomin, A.S. decreased by 3.59% in 2023.

Headquarters
Potocna, 1/1
Cifer; Postal Code: 91943

Contact Details: Purchase the Biomin, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Biomin, A.S. report to view the information.
Outstanding Shares:
Purchase the Biomin, A.S. report to view the information.
Registered Capital:
Purchase the Biomin, A.S. report to view the information.
Incorporation Date:
July 25, 1990
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Biomin, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
19.09%▲
Total operating revenue
6.43%▲
Operating profit (EBIT)
-26.4%▼
EBITDA
2.91%▲
Net Profit (Loss) for the Period
-49.56%▼
Total assets
-7.67%▼
Total equity
3.45%▲
Operating Profit Margin (ROS)
-3.07%▼
Net Profit Margin
-3.59%▼
Return on Equity (ROE)
-4.04%▼
Debt to Equity Ratio
-9.82%▼
Quick Ratio
3.85%▲
Cash Ratio
2.34%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo